Strategic Expansion PSI is a long-standing injectable manufacturer in the MENA region with growing domestic and international reach, presenting a clear opportunity to position new contract manufacturing (CDMO) or co-development partnerships across Asia, Europe, and Africa.

Regulatory footing Operating under SFDA GMP and ISO 13485 for MD, plus adherence to British and US pharmacopeia and GMP, signals strong quality credibility that can be leveraged to pursue high-tier clients seeking compliant manufacturing and global supply reliability.

Quality and Capacity As a leading producer of sterile IV solutions and injectables with a sizable workforce, PSI may benefit from partnerships that scale production capacity, enable technology transfer, or support expedited regulatory approvals for new products.

Recent Partnerships AmpleLogic partnership expansion indicates PSI’s openness to digital enablement and CDMO collaboration, suggesting opportunities for process optimization, ERP/digital offerings, and remote monitoring solutions to drive efficiency.

Financial Backing With reported revenue in the mid-range of tens of millions, PSI presents a mid-market manufacturing profile attractive to vendors offering cost-effective automation, analytics, quality management, and supply chain optimization to improve margins and scale.